About
Reviva Pharmaceuticals Holdings Inc. (RVPH) is a clinical-stage biopharmaceutical firm focused on developing innovative therapies to address central nervous system (CNS) disorders and other significant health challenges. Its lead candidate, RP5063, offers a novel therapeutic approach for treating schizophrenia and mood disorders, underscored by a proprietary drug delivery platform designed to enhance treatment efficacy. With a robust pipeline and a commitment to meeting critical unmet medical needs, Reviva is strategically positioned for growth in the evolving mental health market as it advances through key clinical development milestones.
Advanced charting, extended hours trading, and free stock for new accounts.
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.